BRPI0923486A2 - composicao e método de tratamento de animais não humanos - Google Patents

composicao e método de tratamento de animais não humanos

Info

Publication number
BRPI0923486A2
BRPI0923486A2 BRPI0923486A BRPI0923486A BRPI0923486A2 BR PI0923486 A2 BRPI0923486 A2 BR PI0923486A2 BR PI0923486 A BRPI0923486 A BR PI0923486A BR PI0923486 A BRPI0923486 A BR PI0923486A BR PI0923486 A2 BRPI0923486 A2 BR PI0923486A2
Authority
BR
Brazil
Prior art keywords
treatment
composition
human animals
animals
human
Prior art date
Application number
BRPI0923486A
Other languages
English (en)
Inventor
Frederick Leech Wayne
Original Assignee
Bomac Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Res Limited filed Critical Bomac Res Limited
Publication of BRPI0923486A2 publication Critical patent/BRPI0923486A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0923486A 2008-12-24 2009-12-15 composicao e método de tratamento de animais não humanos BRPI0923486A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ574018A NZ574018A (en) 2008-12-24 2008-12-24 Clostridial vaccine comprising levamisole
PCT/NZ2009/000287 WO2010090532A1 (en) 2008-12-24 2009-12-15 Compositions and dosage regimes comprising a clostridial vaccine and levamisole

Publications (1)

Publication Number Publication Date
BRPI0923486A2 true BRPI0923486A2 (pt) 2018-01-02

Family

ID=42542268

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923486A BRPI0923486A2 (pt) 2008-12-24 2009-12-15 composicao e método de tratamento de animais não humanos

Country Status (13)

Country Link
US (1) US8449893B2 (pt)
EP (1) EP2376113B1 (pt)
AU (1) AU2009339460B2 (pt)
BR (1) BRPI0923486A2 (pt)
DK (1) DK2376113T3 (pt)
ES (1) ES2524083T3 (pt)
HR (1) HRP20141074T1 (pt)
NZ (1) NZ574018A (pt)
PL (1) PL2376113T3 (pt)
PT (1) PT2376113E (pt)
SI (1) SI2376113T1 (pt)
WO (1) WO2010090532A1 (pt)
ZA (1) ZA201105447B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4175183B2 (ja) 2003-06-04 2008-11-05 富士ゼロックス株式会社 高分子光導波路の製造方法
CN111808824B (zh) * 2020-07-20 2022-01-18 中国兽医药品监察所 一种诺维梭菌α毒素的ELISA检测方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191413A (en) * 1978-09-11 1981-10-19 Ici Australia Ltd Anthelmintic and anticlostridial composition containing a tetramisole salt
NZ193807A (en) * 1979-05-31 1983-03-15 Ici Tasman Ltd Improving the response of ruminants to clostridial vaccine by administering tetramisole or levamisole
WO2003037331A1 (en) * 2001-10-29 2003-05-08 Biophage Inc. Use of tetramisole and its derivatives against spore producing microorganisms
US20080286251A1 (en) * 2004-08-02 2008-11-20 Propharmaceuticals, Inc. Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins

Also Published As

Publication number Publication date
SI2376113T1 (sl) 2015-02-27
EP2376113A4 (en) 2012-08-01
US20110311589A1 (en) 2011-12-22
DK2376113T3 (en) 2014-12-08
NZ574018A (en) 2011-03-31
HRP20141074T1 (hr) 2015-01-02
EP2376113B1 (en) 2014-09-24
ZA201105447B (en) 2012-12-27
ES2524083T3 (es) 2014-12-04
US8449893B2 (en) 2013-05-28
PT2376113E (pt) 2014-11-25
PL2376113T3 (pl) 2015-03-31
AU2009339460B2 (en) 2014-04-03
AU2009339460A1 (en) 2011-08-04
WO2010090532A1 (en) 2010-08-12
EP2376113A1 (en) 2011-10-19

Similar Documents

Publication Publication Date Title
PT2517556E (pt) Modelos animais e moléculas terapêuticas
BRPI0908276A2 (pt) Métodos de tratar dor inflamatória
EP2396019A4 (en) METHOD AND COMPOSITIONS FOR TREATING SKIN
EP2391208A4 (en) COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
BRPI1014864A2 (pt) "implante de processos espinhosos e métodos associados"
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI0910897A2 (pt) sistema e método de tratamento de água
BRPI0920284A2 (pt) composição e método
SI2358756T2 (sl) Visokoafinitetna humana protitelesa proti PCSK9
LT3456190T (lt) Antikūną produkuojantis transgeninis pelių pošeimio gyvūnas
BR112012020425A2 (pt) dispositivo e método para tratamento de água
BRPI0912123A2 (pt) Composições de sal e métodos de produção das mesmas
BRPI1006238A2 (pt) método para o tratamento pesticida de plantações e composição
LTPA2016041I1 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
PT3023009T (pt) Conservante de água e rações
BRPI0906094A2 (pt) composto e método de tratamento de diabetes do tipo ii
EP2393351A4 (en) DETERMINATION OF THE SEX AND METHODS FOR SPECIFYING
PL2349231T3 (pl) Kompozycje i metody leczenia chorób kopyta
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BR112012005540A2 (pt) composições e métodos para melhora da função cognitiva e funções relacionadas em animais
BR112012008166A2 (pt) método de tratamento de água e floculante de tratamento de água
BRPI0923534A2 (pt) composição e método para tratamento de doenças de pele
BRPI1006369A2 (pt) cortina para abrigo de animais e abrigo de animais
BRPI1005416A2 (pt) método de modelar cabelos e composição de tratamento capilar
IT1399046B1 (it) Dispositivo e metodo di fissaggio di animali in particolare per mantenerne lo stato in un ambiente sperimentale

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER NEW ZEALAND LIMITED (NZ)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2464 DE 27/03/2018 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2544 DE 08-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.